管理免疫检查点抑制剂相关性胃炎：见解和策略。
Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies.
发表日期：2024 Jun 28
作者：
Li-Li Yu, Zhi-Lin He, Xin-Lai Qian
来源：
PHARMACOLOGY & THERAPEUTICS
摘要：
免疫检查点抑制剂（ICIs）因其在治疗各种肿瘤方面的有效性而被广泛使用。免疫相关不良事件 (irAE) 定义为 ICI 治疗引起的不良反应。胃肠道irAE是一种常见的irAE，其特征是肠道副作用，例如腹泻和结肠炎，这可能导致ICIs的停药。©作者2024。百事登出版集团有限公司出版。保留所有权利。
Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs.©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.